25 April 2024 – trading update Strong first quarter results from pharmaceutical group AstraZeneca have resulted in the shares rising to over £120 compared with…
25 April 2024 – director dealing Non-executive director Barney Kent has purchased 9,656 shares in the company at 258.89p. This purchase worth around £25,000 is…
22 April 2024 – notice of results The AIM-listed pharmaceutical group has been forced to delay its annual results’ announcement once again as the auditors,…
22 April 2024 – new contract The company has announced yet another new contract, this time in Sweden, for its transport information systems which will…
18 April 2024 – final results The AIM-listed technology group has announced its annual results for 2023 and these make for encouraging reading. Revenues for…
In this issue... our share tips for April 2024, the latest on our Aggressive Portfolio IX, plus company features and market insight.Now You're Talking! Those...
This website uses cookies to improve your experience. We'll assume you're ok with this, but you can opt-out if you wish. Cookie settingsACCEPT
Privacy & Cookies Policy
Privacy Overview
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
